A Noninvasive Urine Test Can Detect Cancer Cells
MIT engineers have created a diagnostic nanoparticle that can identify cancer through a urine test and act as an imaging agent, pinpointing the tumor location.
Read MorePosted by Chris Wolski | Jul 16, 2021 | Colorectal, Urinalysis & Toxicology |
MIT engineers have created a diagnostic nanoparticle that can identify cancer through a urine test and act as an imaging agent, pinpointing the tumor location.
Read MorePosted by Chris Wolski | Jul 15, 2021 | Osmometer |
ELITechGroup, a provider of global vapor pressure osmometer technology, has acquired GONOTEC, a...
Read MorePosted by Melanie Hamilton-Basich | Jul 7, 2021 | Unknown Origin & Other Cancer Types, Urinalysis & Toxicology |
The urine test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus and a panel of biomarkers validated by Birmingham University researchers to diagnose bladder cancer.
Read MorePosted by Chris Wolski | Jul 2, 2021 | Covid 19, Rapid Assays |
Enzo Biochem, Inc., and CLX Health have announced a collaboration to provide rapid access to COVID-19 PCR testing for international travel.
Read MorePosted by Chris Wolski | Jun 29, 2021 | Immunoassay |
Inova Diagnostics announced FDA 510(k) clearance of its Aptiva System and Aptiva Celiac Disease IgA assay.
Read More